Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.125.1 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.78 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.78 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.159NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.159NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.43.5 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.5 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
A.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.422NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.422NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.56NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.4.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.7NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.198NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.198NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.2.6.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.6.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.47.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.47.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.8US
XBF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
CF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CF.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
CM.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.11NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
DN.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.3.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FW.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FW.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
CH.1.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.29NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.55NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.14NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.35NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FK.1.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.4.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26650.4US
B.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.13NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
DR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DR.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.160.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used